Triplet Could Become a New Standard in Tough-to-Treat CLL

Published Date: 06 Jul 2026

Adding a non-covalent BTK inhibitor improved progression-free survival

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

2.

A novel blood test may enable the early identification of common, fatal cancers.

3.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

4.

Breast cancer: A new target to eliminate dormant cells before they wake

5.

Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot